Clinical Evidence for the Choice of the Direct Oral Anticoagulant in Patients with Atrial Fibrillation According to Creatinine Clearance

• 主要な著者: Riccardo Vio (著者), Riccardo Proietti (著者), Matteo Rigato (著者), Lorenzo Arcangelo Calò (著者)
• フォーマット: 図書
• 出版事項: MDPI AG, 2021-03-01T00:00:00Z.
• 主題: article
• オンライン･アクセス: Connect to this object online.

Atrial fibrillation (AF) often coexists with chronic kidney disease (CKD), which confer to the patient a higher risk of both thromboembolic and hemorrhagic events. Oral anticoagulation therapy, nowadays preferably with direct oral anticoagulants (DOACs), represents the cornerstone for ischemic strok...